Your session is about to expire
← Back to Search
Telerehabilitation for Lung Cancer
N/A
Waitlist Available
Led By Duc M. Ha, MD MAS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult Veterans with a history of stage I-IIIA lung cancer
Completed curative intent therapy (i.e., lung cancer resection surgery, definitive radiation, or concurrent chemoradiation) within 1-6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up difference in changes in c30/lc29 between baseline and week 12 and week 24
Awards & highlights
Study Summary
This trial will evaluate a telerehabilitation intervention for US Veterans with lung cancer to improve function and quality of life.
Who is the study for?
This trial is for U.S. Veterans who have had stage I-IIIA lung cancer and finished their main treatment between 1-6 months ago. They must be able to follow directions and consent to the study, with a life expectancy over 6 months, no severe heart or lung disease, major orthopedic issues, or conditions that would stop them from doing exercises via telerehabilitation.Check my eligibility
What is being tested?
The study tests a telerehabilitation program designed to help improve function and quality of life in Veterans after lung cancer treatment. It's about finding out if rehabilitation services can be effectively delivered remotely and how they impact survivors' health outcomes.See study design
What are the potential side effects?
Since this trial involves exercise through telerehabilitation rather than medication, side effects may include typical exercise-related discomforts such as muscle soreness or fatigue but should not involve drug-related side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a veteran who had early-stage lung cancer.
Select...
I finished my cancer treatment aimed at curing it between 1 to 6 months ago.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ difference in changes in c30/lc29 between baseline and week 12 and week 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~difference in changes in c30/lc29 between baseline and week 12 and week 24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mobile Six-Minute Walk Distance
Secondary outcome measures
30-Second Arm Curls
30-Second Chair-Stand
European Organization for Research and Treatment Cancer QoL Questionnaire Core 30 and Lung Cancer Module 29 (C30/LC29)
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TelerehabilitationExperimental Treatment1 Intervention
Telerehabilitation intervention consisting of exercise training, education, and behavioral support
Group II: ControlActive Control1 Intervention
No intervention arm, with assessment of functional and patient-reported outcomes only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telerehabilitation
2017
N/A
~1120
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,563 Total Patients Enrolled
Duc M. Ha, MD MASPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are expected to live for less than 6 months.I have conditions related to my bones or muscles, like having both legs amputated below the knee.I am a veteran who had early-stage lung cancer.I finished my cancer treatment aimed at curing it between 1 to 6 months ago.I can follow directions and provide informed consent.Veterans with health conditions that prevent them from doing exercise and remote rehabilitation.I do not have severe heart or lung disease.You are currently receiving care in a hospice.
Research Study Groups:
This trial has the following groups:- Group 1: Telerehabilitation
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the current study seeking new participants?
"The clinical trial registry confirms that this medical experiment is no longer enrolling patients. It was posted on April 1st 2023 and last modified December 16th 2021. However, there are currently 1631 other trials in need of candidates."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger